These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22541601)

  • 1. Therapeutic management of orally treated type 2 diabetic patients, by French general practitioners in 2010: the DIAttitude Study.
    Halimi S; Balkau B; Attali C; Detournay B; Amelineau E; Blickle JF
    Diabetes Metab; 2012 Mar; 38 Suppl 3():S36-46. PubMed ID: 22541601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetes treatment intensification in general practice in France in 2008-2009: the DIAttitude Study.
    Balkau B; Bouée S; Avignon A; Vergès B; Chartier I; Amelineau E; Halimi S
    Diabetes Metab; 2012 Mar; 38 Suppl 3():S29-35. PubMed ID: 22541600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons for non-intensification of treatment in people with type 2 diabetes receiving oral monotherapy: Outcomes from the prospective DIAttitude study.
    Balkau B; Halimi S; Blickle JF; Vergès B; Avignon A; Attali C; Chartier I; Amelineau E
    Ann Endocrinol (Paris); 2016 Dec; 77(6):649-657. PubMed ID: 27646493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current insulin therapy in patients with type 2 diabetes: results of the ADHOC survey in France.
    Penfornis A; San-Galli F; Cimino L; Huet D
    Diabetes Metab; 2011 Nov; 37(5):440-5. PubMed ID: 21493117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of people with type 2 diabetes with hypoglycaemic agents in primary care: retrospective cohort study.
    Calvert MJ; McManus RJ; Freemantle N
    Fam Pract; 2007 Jun; 24(3):224-9. PubMed ID: 17488736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients.
    Davidson J; Koro C; Arondekar B; Lee BH; Fedder D
    Clin Ther; 2008 Feb; 30(2):287-93. PubMed ID: 18343267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic inertia in type 2 diabetes: insights from the PANORAMA study in France.
    Simon D
    Diabetes Metab; 2012 Mar; 38 Suppl 3():S47-52. PubMed ID: 22541602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatments.
    Won HK; Kim KJ; Lee BW; Kang ES; Cha BS; Lee HC
    Diabet Med; 2012 Jan; 29(1):74-9. PubMed ID: 21781151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
    Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
    Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care.
    Cook MN; Girman CJ; Stein PP; Alexander CM
    Diabet Med; 2007 Apr; 24(4):350-8. PubMed ID: 17335466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of self-management education for patients with Type 2 diabetes taking maximal oral hypoglycaemic therapy: a randomized trial in primary care.
    Goudswaard AN; Stolk RP; Zuithoff NP; de Valk HW; Rutten GE
    Diabet Med; 2004 May; 21(5):491-6. PubMed ID: 15089797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensification of diabetes medication and risk for 30-day readmission.
    Wei NJ; Wexler DJ; Nathan DM; Grant RW
    Diabet Med; 2013 Feb; 30(2):e56-62. PubMed ID: 23126686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain.
    Conthe P; Mata M; Orozco D; Pajuelo F; Barreto CS; Anaya SF; Gomis R
    Diabetes Res Clin Pract; 2011 Jan; 91(1):108-14. PubMed ID: 21035225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy.
    Fu AZ; Qiu Y; Davies MJ; Radican L; Engel SS
    Diabetes Obes Metab; 2011 Aug; 13(8):765-9. PubMed ID: 21457427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT study.
    Huppertz E; Pieper L; Klotsche J; Stridde E; Pittrow D; Böhler S; Lehnert H
    Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):6-14. PubMed ID: 18465681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.
    Currie CJ; Peters JR; Tynan A; Evans M; Heine RJ; Bracco OL; Zagar T; Poole CD
    Lancet; 2010 Feb; 375(9713):481-9. PubMed ID: 20110121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.
    Lecomte P; Romon I; Fosse S; Simon D; Fagot-Campagna A
    Diabetes Metab; 2008 Jun; 34(3):219-26. PubMed ID: 18343703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study.
    Penfornis A; Blicklé JF; Fiquet B; Quéré S; Dejager S
    Vasc Health Risk Manag; 2014; 10():341-52. PubMed ID: 24966684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes.
    Rosenstock J; Aguilar-Salinas C; Klein E; Nepal S; List J; Chen R;
    Curr Med Res Opin; 2009 Oct; 25(10):2401-11. PubMed ID: 19650754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.